Healthcare101

 The prefilled syringes market is expected to generate a revenue of USD 13.1 billion in 2030, with a revenue of USD 7.1 billion in 2024 to register a CAGR of 10.8%. A prefilled syringe is a convenient medical device for delivering parenteral medications, offering a premeasured single-dose. This syringe benefits manufacturers by minimizing drug waste and extending product lifespan, while also making self-administration easier for patients at home or outside of hospital settings. Drugs commonly packaged in prefilled syringes include biologics, vaccines, blood stimulants, therapeutic proteins, erythropoietin products, and interferons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=16618331 Prefilled Syringes Market Dynamics Driver: Increasing prevalence of chronic diseases The prefilled syringe market growth is largely being driven by the rising prevalence of chronic diseases like diabetes, cardiovascular disease, and autoimmune disorders. Pr...

 The size of global prefilled syringes market in terms of revenue was estimated to be worth $5.6 billion in 2020 and is poised to reach $8.6 billion by 2025, growing at a CAGR of 9.0% from 2020 to 2025. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=16618331 Increasing adoption of self-administered injectable drugs is expected to result in the segment occupying the majority of the industry share The conventional Prefilled Syringes Market is estimated to have the largest market share by value. Growth of this segment can be attributed to the the advantages offered, such as safe administration, ease of use for both healthcare professionals and end users, reduced risk of contamination of the product, less waste of costly API, ease of manufacturing, improved dosing accuracy, and enh...

 According to the new market research report " Prefilled Syringes Market by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) - Global Forecast to 2025", published by MarketsandMarkets™, is estimated to be USD 5.6 billion in 2020 and projected to reach USD 8.6 billion by 2025, at a CAGR of 9.0%. The Rising target disease population, rapid growth in generic products, rising adoption of self-medication and digitalization, affordable cost with increased efficiency, and technological advancements are the major factors driving the growth of the market. Furthermore, growing initiatives undertaken by leading market players to establish production facilities in both mature and developing markets are the key factors driving the growth of the prefilled syringes industry. Browse and in-depth TOC on " Conventional Prefilled Syringe...

  The Global Prefilled Syringes Market size is projected to reach USD 8.6 billion by 2025 from USD 5.6 billion in 2020, at a CAGR of 9.0% during the forecast period. growth in the prefilled syringes market is majorly driven by the rising demand for prefilled syringes is attributed to the growing prevalence of chronic diseases, technological advancements, rising adoption of self-injecting parenteral devices, and supportive government regulations (especially needlestick legislations). In addition, growing awareness on the benefits of prefilled syringes among patients and healthcare professionals, along with the growing number of biologics and biosimilars in the pharmaceuticals market, is supporting the growth of the prefilled syringes market. Get Sample PDF: https://www.marketsandmarkets.com/requestsampleNew.asp?id=16618331 Key Market Players Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (US), Baxter Interna...